Valuation: CardioGenics Holdings Inc

Market Cap 382K 336K 310K 290K 542K 36.07M 553K 3.72M 1.44M 17.79M 1.43M 1.4M 61.83M P/E 2014
-2.3x
P/E 2015 -2.17x
Enterprise Value 539K 474K 436K 408K 764K 50.84M 780K 5.24M 2.03M 25.07M 2.02M 1.98M 87.15M EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
97.49%
Yield 2014 *
-
Yield 2015 -
1 month 0
Extreme 0
0
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0.11
10 years 0
Extreme 0
0.29
Manager TitleAgeSince
Chief Executive Officer 68 2009-10-26
Director of Finance/CFO 78 2010-06-15
Investor Relations Contact 65 -
Director TitleAgeSince
Director/Board Member 68 2011-04-05
Chairman 76 2010-06-15
Director/Board Member 65 2010-06-15
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 142
+4.37%+10.71%+185.94%+302.31% 18.16B
+2.86%+3.47%-41.83%-22.83% 9.13B
+3.97%+5.64%+34.66%+17.82% 6.83B
+3.03%+4.70%-32.49% - 5.13B
+2.11%-0.28%-25.15%-31.24% 4.81B
+5.55%+7.48%+99.14%+101.60% 4.18B
+3.27%+11.20%+228.10%-34.58% 4.39B
-0.12%+2.85%-29.87%-30.91% 4B
-0.87%-4.61%-20.88%-44.47% 2.51B
Average +2.42%+1.67%+44.18%+32.21% 5.91B
Weighted average by Cap. +3.27%+2.88%+70.82%+97.95%

Financials

2014 2015
Net sales - -
Net income -2.68M -2.36M -2.17M -2.03M -3.8M -253M -3.88M -26.08M -10.09M -125M -10.06M -9.84M -434M -1.92M -1.69M -1.55M -1.45M -2.72M -181M -2.77M -18.65M -7.21M -89.18M -7.2M -7.04M -310M
Net Debt 132K 116K 107K 100K 188K 12.48M 191K 1.29M 498K 6.15M 497K 486K 21.39M 157K 138K 127K 119K 222K 14.77M 227K 1.52M 589K 7.28M 588K 575K 25.32M
Logo CardioGenics Holdings Inc
CardioGenics Holdings Inc. is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. The Company has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.
Employees
4
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. CGNH Stock